COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals
with uncontrolled glucose levels are more prone to develop the severe form of COVID-…

Brazil currently has one of the fastest-growing severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) epidemics in the world. Because of limited available data, assessments …

Level of evidence Level A Data obtained from multiple concordant large randomized trials
and/or robust meta-analysis of randomized clinical trials Level B Data obtained from less …

Randomized trials have established that statin treatment reduces coronary events in primary
prevention and in patients with stable coronary artery disease. In unstable coronary artery …

Hypertension, a prevalent risk factor for cardiovascular disease, frequently occurs in
conjunction with metabolic disturbances and in particular with dyslipidaemia; such comorbidity …

Patients with type 2 diabetes have a several-fold increased risk of developing cardiovascular
disease when compared with nondiabetic controls. Myocardial infarction and stroke are …

Patients with type 2 diabetes (T2DM) have a substantial risk of developing cardiovascular
disease. The strong connection between the severity of hyperglycaemia, metabolic changes …

Atherosclerosis, the underlying cause of cardiovascular disease (CVD), is a worldwide
cause of morbidity and mortality. Reducing ApoB-containing lipoproteins—chiefly, LDL (low-…

OBJECTIVE Like mutations with loss of function in the proprotein convertase subtilisin/kexin
type 9 (PCSK9) gene, inhibitors of PCSK9 (PCSK9i) may potentially favor the manifestation …

A general concept of clinical benefit of vitamin D supplementation has emerged from the
evidence in prevention of osteoporosis. From the cardiovascular point of view, clinical benefit of …